Balaxi Pharmaceuticals Ltd Share Price
As on 18 November 2025 at 23:55 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-12.65%
Over 6 Months
-34.43%
Over 1 Year
-54.07%
Over 3 Years
-69.84%
Balaxi Pharmaceuticals Ltd Summary
Close ₹35.92
Open ₹37.43
High ₹37.90
Low ₹35.67
Volume 1,38,878
Net Turnover (in Cr) ₹0.5
52Wk High -
52Wk Low -
52Wk High / Low
-
-
Balaxi Pharmaceuticals Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹198.31
EPS (TTM) 0.73
Book Value (BV) 23.78
Div. Yield -
P/E (TTM) 49.21
Price/Book Value 1.51
Delivery % 76.68 %
Face Value 2
Key Ratios
PE Ratio 98.34
PB Ratio 2.76
EV to Sales 5.84
PEG Ratio -32.94
ROA 2.25
ROE 2.89
Debt-Equity 0.19
Net Profit Margin 5.90
Operating Profit Margin 13.08
Balaxi Pharmaceuticals Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 294.92 | 241.93 | 339.07 | 284.36 | 233.56 |
| Total Expenses | 266.25 | 201.62 | 282.15 | 229.84 | 189.23 |
| Profit Before Tax | 28.67 | 2.02 | 56.92 | 54.52 | 44.33 |
| Profit After Tax | 25.07 | -2.39 | 45.96 | 47.66 | 38.14 |
| Operating Profit After Depreciation | 31.60 | 41.99 | 57.42 | 54.66 | 44.34 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 40.98 | 40.88 | 41.41 | 28.76 | 2.45 |
| Total Non Current Assets | 67.58 | 48.17 | 46.16 | 35.47 | 5.91 |
| Total Current Assets | 242.77 | 210.17 | 193.51 | 141 | 93.77 |
| Total Assets | 310.34 | 258.34 | 239.67 | 176.47 | 99.68 |
| Total Shareholder's Fund | 231.74 | 201.36 | 182.88 | 113.16 | 64.98 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -35 | 4.87 | 6.08 | 34.14 | - |
| Net Cash Used In Investing Activities | -21.76 | -1.05 | -10.57 | -28.45 | -5.97 |
| Net Cash Used In Financing Activities | 33.88 | 30.25 | 25.51 | -0.16 | 3.65 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 66.36 | 72.59 | 114.74 | 104.04 | 88.68 |
| Total Expenses | 61.07 | 67.01 | 92.29 | 84.34 | 68.08 |
| Profit Before Tax | 5.29 | 5.58 | 22.45 | 19.70 | 20.60 |
| Profit After Tax | 3.60 | 3.65 | 16.22 | 14.67 | 15.13 |
| Operating Profit After Depreciation | 7.35 | 7.12 | 22.91 | 19.76 | 20.61 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 6.67 | 7.10 | 7.89 | 2.20 | 0.69 |
| Total Non Current Assets | 54.84 | 31.46 | 30.70 | 27.84 | 20.25 |
| Total Current Assets | 119.60 | 122.90 | 99.02 | 54.08 | 48.67 |
| Total Assets | 174.45 | 154.36 | 129.72 | 81.92 | 68.92 |
| Total Shareholder's Fund | 127.85 | 121.55 | 92.11 | 57.91 | 43.25 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -7.60 | -1.83 | -7.07 | 8.89 | 13.46 |
| Net Cash Used In Investing Activities | -24.98 | 0.46 | -2.29 | -6.87 | -20.03 |
| Net Cash Used In Financing Activities | 17.21 | 27.55 | 26.39 | -1.64 | 3.49 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 56.18 | 70.74 | 76.27 | 73.29 | 77.38 |
| Total Expenses | 55.01 | 66.60 | 63.71 | 69.30 | 66.80 |
| Profit Before Tax | 1.39 | 0.89 | 9.67 | 6.07 | 5.56 |
| Profit After Tax | 0.21 | 0.29 | 8.64 | 5.36 | 4.59 |
| Operating Profit after Depreciation | 2.76 | 2.36 | 10.87 | 7.93 | 6.47 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 19.31 | 16.71 | 9.65 | 11.16 | 21.16 |
| Total Expenses | 18.54 | 16.17 | 10.30 | 11.06 | 19.67 |
| Profit Before Tax | 4.24 | 0.26 | -1.13 | 2.34 | 2.21 |
| Profit After Tax | 3.26 | 0.19 | -1.18 | 1.74 | 1.66 |
| Operating Profit after Depreciation | 4.98 | 1 | -0.33 | 3.02 | 2.78 |
Balaxi Pharmaceuticals Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 35.09
S2 34.27
S3 32.86
Pivot 36.50
R1 37.32
R2 38.73
R3 39.55
Moving Average
20 SMA 41.17
50 SMA 43.25
100 SMA 45.72
200 SMA 52.77
Balaxi Pharmaceuticals Ltd Corporate Actions
Balaxi Pharmaceuticals Ltd
₹0.5/Share
Announcement Date 01 Jul 2022
Record Date 04 Jul 2022
Div Yield 5%
Balaxi Pharmaceuticals Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Balaxi Pharmaceuticals Ltd Top Mutal Funds Invested
No data available
Balaxi Pharmaceuticals Ltd News
Balaxi Pharmaceuticals to announce Quarterly Result
On 11 November 2025
05 Nov 2025, 04:40 pm
Balaxi Pharmaceuticals to announce Quarterly Result
On 5 August 2025
30 Jul 2025, 11:37 am
Balaxi Pharmaceuticals AGM scheduled
On 25 August 2025
02 Jun 2025, 10:41 am
Balaxi Pharmaceuticals to convene board meeting
On 30 May 2025
22 May 2025, 07:48 pm
Balaxi Pharmaceuticals to convene board meeting
On 10 February 2025
03 Feb 2025, 10:51 am
Balaxi Pharmaceuticals Ltd Stock Analysis
- Annual revenue for Balaxi Pharmaceuticals Ltd decreased by 8.59% to ₹66.36 crore in FY 2025 from ₹72.59 crore in FY 2024.
- Annual Net Profit for Balaxi Pharmaceuticals Ltd decreased by 1.34% to ₹3.60 crore in FY 2025 from ₹3.65 crore in FY 2024.
- Promoter Shareholding in Balaxi Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 65.99% in June 2025 to 65.99% in September 2025.
- Balaxi Pharmaceuticals Ltd delivered a 1-year return of -54.07% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Balaxi Pharmaceuticals Ltd share price moved up by 0.22% from its previous close of INR ₹35.92. The latest Balaxi Pharmaceuticals Ltd share price is INR ₹36.
- Balaxi Pharmaceuticals Ltd share price today has been at a low of 35.75 and a high of 36.64. Over the past 52 weeks, the Balaxi Pharmaceuticals Ltd share price has seen a low of 35.67 and a high of 85.58.
FAQ’s
What is the share price of Balaxi Pharmaceuticals Ltd today?
Balaxi Pharmaceuticals Ltd share price as on 18 Nov 2025 is ₹ 36.0
What is the Market Cap of Balaxi Pharmaceuticals Ltd?
The market cap of Balaxi Pharmaceuticals Ltd stock is ₹198.31 Cr.
What is the PE Ratio of Balaxi Pharmaceuticals Ltd?
The Price to Earnings (P/E) Ratio of Balaxi Pharmaceuticals Ltd is 98.34
What is the PB Ratio of Balaxi Pharmaceuticals Ltd?
The Price to Book (P/B) Ratio of Balaxi Pharmaceuticals Ltd is 2.76
What is the 52 week high of Balaxi Pharmaceuticals Ltd Share Price?
The 52 week high of Balaxi Pharmaceuticals Ltd share price stands at ₹-
What is the 52 week low of Balaxi Pharmaceuticals Ltd Share Price?
The 52 week low of Balaxi Pharmaceuticals Ltd share price stands at ₹-
How can I buy shares of Balaxi Pharmaceuticals Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Balaxi Pharmaceuticals Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
